Second cancer immunotherapy partnership with 3T Bio Second cancer immunotherapy partnership with 3T Bio Second cancer immunotherapy partnership with 3T Bio
Accelerating new cancer medicines in partnership with CBmed Accelerating new cancer medicines in partnership with CBmed Boehringer Ingelheim and CBmed join forces to translate novel cancer therapy approaches faster into new medicines for patients
Major investment for respiratory diseases completed Major investment for respiratory diseases completed 105 million euros invested into expansion of production facilities in Ingelheim and Dortmund
Shared science for the best cat diabetes management Shared science for the best cat diabetes management Diabetes mellitus is a common endocrine disease with increasing prevalence in dogs and cats. Learn how science's made management easier.
Striving to revolutionize mental health research Striving to revolutionize mental health research World Mental Health Day: Through a precision psychiatry approach and rich pipeline, we are committed to transforming the mental health landscape.
Partnering-with-google-in-quantum-computing Partnering-with-google-in-quantum-computing New cooperation with Google explores the potentials of quantum computing for pharma R&D.
Clinical-phase2-trials-NASH-and-obesity Clinical-phase2-trials-NASH-and-obesity Boehringer Ingelheim and Zealand Pharma announced Phase 2 trials of the GLP-1/glucagon dual agonist BI 456906 for adults living with obesity or NASH.
Boehringer Ingelheim Second Transforming Science Day Boehringer Ingelheim Second Transforming Science Day World-renowned top scientists and companies in R&D take the stage at Boehringer Ingelheim’s second Transforming Science Day
Innovation in medicinal chemistry Innovation in medicinal chemistry Darryl McConnell, Research Site Head, Austria and Jürgen Mack, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
Nerandomilast primary endpoint phase-3 FIBRONEER-IPF met Nerandomilast primary endpoint phase-3 FIBRONEER-IPF met Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
EU approved Jardiance for type 2 diabetes in children EU approved Jardiance for type 2 diabetes in children Jardiance® (empagliflozin) receives approval in the EU for the treatment of type 2 diabetes in children aged 10 years and above
new_analysis_nintedanib_SSc_ILD new_analysis_nintedanib_SSc_ILD Interim analysis results support long term treatment with nintedanib in SSc-ILD patients
Ingelheim Ingelheim The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany.
Supply Chain Scholarship for Cowtribe Supply Chain Scholarship for Cowtribe A supply chain course we sponsored boosted the career of Latifa Saaka
Mastitis dairy cows prevent antibiotic resistance Mastitis dairy cows prevent antibiotic resistance The Clinical and Laboratory Standards Institute (CLSI) approved revised interpretive criteria for the susceptibility testing of a mastitis product.
AUROBAC's Strategy & Pipeline Against Severe Infections & Resistance AUROBAC's Strategy & Pipeline Against Severe Infections & Resistance AUROBAC THERAPEUTICS presents strategy and growing pipeline to tackle severe infections and antimicrobial resistance
Employees empower small dairy producers Employees empower small dairy producers Boehringer Ingelheim social intrapreneurship helps farmers improve animal welfare and the well-being of rural communities in Southern India.
Purpose: Finding the long-missed meaning Purpose: Finding the long-missed meaning Cancer survivor Missy Pappion is happy at Boehringer Ingelheim after climbing the corporate ladder
Stroke Risk Factors Symptoms Stroke Risk Factors Symptoms Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. There is a simple test that can help everyone identify the most common symptoms of a stroke.
global-top-employer global-top-employer For the first time, Boehringer Ingelheim receives the award as a Global Top Employer as well as individual awards in 27 countries.
Award: Boehringer Ingelheim is Global Top Employer 2022 Award: Boehringer Ingelheim is Global Top Employer 2022 Global Top Employer 2022
Animal Welfare through environmental sustainability Animal Welfare through environmental sustainability Producing honey and contributing to environmental sustainability during your work hours.
Boehringer partners with NCD Alliance Boehringer partners with NCD Alliance Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities
Larry’s Story: Advocating for people with lung cancer Larry’s Story: Advocating for people with lung cancer In 2013, Larry was diagnosed with non-small cell lung cancer. Learn how his diagnosis led him on a journey of patient advocacy for others with cancer.